Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer

Edesa Biotech receives FDA clearance to expand EB06 vitiligo study into the US

LTR Pharma launches Roxus nasal spray for ED in the US

Galderma reports sustained symptom improvements with nemolizumab in children with atopic dermatitis

KDventures portfolio company Modus Therapeutics pauses Phase 2a trial enrolment, delays expected readout

Philips-led EXIT-CVD consortium launches cardiovascular clinical studies across Europe

SciBase technology selected as primary endpoint in NIH-led skin exposure study

Continuity Biosciences awarded Gates Foundation grant to advance ultra-long-acting implant for HIV prevention

Genezen agrees manufacturing collaboration with Galibra Neuroscience

Viking Therapeutics launches Phase 3 clinical programme for oral VK2735 in obesity

Coya Therapeutics plans open-label extension of COYA 302 ALS trial

Takeda reports positive Phase 2/3 results for investigational immunodeficiency therapy

Galderma to acquire ZO Skin Health for USD1.5bn to expand skincare portfolio

Orexo reports encouraging initial bioavailability results for oral semaglutide formulation